IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,889,037 | +114.4% | 2,198,427 | +154.9% | 0.00% | +100.0% |
| Q2 2023 | $16,273,904 | +337.5% | 862,422 | -11.0% | 0.00% | – |
| Q1 2023 | $3,720,120 | +346279.9% | 968,733 | +347.5% | 0.00% | – |
| Q4 2022 | $1,074 | -99.8% | 216,467 | +62.1% | 0.00% | – |
| Q3 2022 | $638,000 | +12.3% | 133,504 | +5.9% | 0.00% | – |
| Q2 2022 | $568,000 | -5.0% | 126,052 | +0.4% | 0.00% | – |
| Q1 2022 | $598,000 | -15.7% | 125,573 | +31.5% | 0.00% | – |
| Q4 2021 | $709,000 | +41.8% | 95,461 | +8.1% | 0.00% | – |
| Q3 2021 | $500,000 | -12.7% | 88,270 | +1.4% | 0.00% | – |
| Q2 2021 | $573,000 | -2.4% | 87,012 | +20.1% | 0.00% | – |
| Q1 2021 | $587,000 | +4.4% | 72,478 | -16.8% | 0.00% | – |
| Q4 2020 | $562,000 | +128.5% | 87,087 | +25.7% | 0.00% | – |
| Q3 2020 | $246,000 | -12.1% | 69,290 | +13.5% | 0.00% | – |
| Q2 2020 | $280,000 | +42.1% | 61,049 | +5.6% | 0.00% | – |
| Q1 2020 | $197,000 | -89.7% | 57,835 | -84.6% | 0.00% | – |
| Q4 2019 | $1,916,000 | +903.1% | 375,454 | +373.7% | 0.00% | – |
| Q3 2019 | $191,000 | -93.4% | 79,253 | -94.3% | 0.00% | -100.0% |
| Q2 2019 | $2,874,000 | +2717.6% | 1,401,637 | +3608.5% | 0.00% | – |
| Q1 2019 | $102,000 | -46.0% | 37,795 | -3.8% | 0.00% | – |
| Q4 2018 | $189,000 | -44.1% | 39,301 | +10.2% | 0.00% | – |
| Q3 2018 | $338,000 | +25.2% | 35,657 | +28.2% | 0.00% | – |
| Q2 2018 | $270,000 | +18.9% | 27,820 | +29.1% | 0.00% | – |
| Q1 2018 | $227,000 | -91.8% | 21,542 | -95.0% | 0.00% | -100.0% |
| Q4 2017 | $2,773,000 | +46116.7% | 432,662 | +54598.1% | 0.00% | – |
| Q3 2017 | $6,000 | +20.0% | 791 | +15.8% | 0.00% | – |
| Q2 2017 | $5,000 | -99.3% | 683 | -99.6% | 0.00% | – |
| Q1 2017 | $725,000 | +72400.0% | 187,230 | +37346.0% | 0.00% | – |
| Q4 2016 | $1,000 | – | 500 | +415.5% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 97 | -92.4% | 0.00% | – |
| Q1 2016 | $11,000 | +450.0% | 1,282 | +686.5% | 0.00% | – |
| Q4 2015 | $2,000 | -99.8% | 163 | -99.8% | 0.00% | – |
| Q3 2013 | $1,302,000 | -25.7% | 76,467 | -27.6% | 0.00% | -100.0% |
| Q2 2013 | $1,752,000 | – | 105,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |